Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photobiomodulation and CPP-ACPF for Post-Whitening Sensitivity
NCT05298059Completed
- Sponsor
- Universidade Federal do Pará
- Start
- Mar 2022
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of casein phosphopeptide-amorphous calcium phosphate in dentin hypersensitivity (DH) (4 arms), sponsored by Universidade Federal do Pará. Primary endpoint: Sensitivity assessment using Visual Analogue Scale. Started Mar 2022; status: completed.
02
Drugs
casein phosphopeptide-amorphous calcium phosphate
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT05298059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05298059.